WallStreetZenWallStreetZen

NASDAQ: BGLC
Bionexus Gene Lab Corp Stock

$0.42+0.00 (+0%)
Updated Oct 7, 2024
BGLC Price
$0.42
Fair Value Price
N/A
Market Cap
$7.60M
52 Week Low
$0.31
52 Week High
$3.39
P/E
-3.28x
P/B
0.8x
P/S
0.91x
PEG
N/A
Dividend Yield
N/A
Revenue
$9.18M
Earnings
-$2.21M
Gross Margin
13.9%
Operating Margin
-22.77%
Profit Margin
-24%
Debt to Equity
0.17
Operating Cash Flow
-$2M
Beta
5.5
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BGLC Overview

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Zen Score

Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BGLC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BGLC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BGLC is good value based on its book value relative to its share price (0.8x), compared to the US Specialty Chemicals industry average (3.61x)
P/B vs Industry Valuation
BGLC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BGLC due diligence checks available for Premium users.

Be the first to know about important BGLC news, forecast changes, insider trades & much more!

BGLC News

Valuation

BGLC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.28x
Industry
32.9x
Market
26.63x

BGLC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.8x
Industry
3.61x
BGLC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BGLC's financial health

Profit margin

Revenue
$2.0M
Net Income
$199.1k
Profit Margin
10.1%
BGLC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BGLC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$11.1M
Liabilities
$1.6M
Debt to equity
0.17
BGLC's short-term assets ($7.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BGLC's short-term assets ($7.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BGLC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BGLC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$670.5k
Investing
$83.1k
Financing
$173.6k
BGLC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BGLC vs Specialty Chemical Stocks

TickerMarket Cap1d %P/EP/B
BGLC$7.60M+0.24%-3.28x0.80x
CRKN$5.00M-4.20%0.00x0.57x
CNEY$2.23M-3.84%-0.34x0.02x
SNES$1.17M-6.20%0.04x0.38x
FSI$41.96M+1.20%15.32x1.16x

Bionexus Gene Lab Stock FAQ

What is Bionexus Gene Lab's quote symbol?

(NASDAQ: BGLC) Bionexus Gene Lab trades on the NASDAQ under the ticker symbol BGLC. Bionexus Gene Lab stock quotes can also be displayed as NASDAQ: BGLC.

If you're new to stock investing, here's how to buy Bionexus Gene Lab stock.

What is the 52 week high and low for Bionexus Gene Lab (NASDAQ: BGLC)?

(NASDAQ: BGLC) Bionexus Gene Lab's 52-week high was $3.39, and its 52-week low was $0.31. It is currently -87.52% from its 52-week high and 36.45% from its 52-week low.

How much is Bionexus Gene Lab stock worth today?

(NASDAQ: BGLC) Bionexus Gene Lab currently has 17,967,663 outstanding shares. With Bionexus Gene Lab stock trading at $0.42 per share, the total value of Bionexus Gene Lab stock (market capitalization) is $7.60M.

Bionexus Gene Lab stock was originally listed at a price of $2.45 in Nov 20, 2020. If you had invested in Bionexus Gene Lab stock at $2.45, your return over the last 3 years would have been -82.73%, for an annualized return of -44.32% (not including any dividends or dividend reinvestments).

How much is Bionexus Gene Lab's stock price per share?

(NASDAQ: BGLC) Bionexus Gene Lab stock price per share is $0.42 today (as of Oct 7, 2024).

What is Bionexus Gene Lab's Market Cap?

(NASDAQ: BGLC) Bionexus Gene Lab's market cap is $7.60M, as of Oct 8, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bionexus Gene Lab's market cap is calculated by multiplying BGLC's current stock price of $0.42 by BGLC's total outstanding shares of 17,967,663.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.